<VariationArchive VariationID="2630008" VariationName="NM_000346.4(SOX9):c.164dup (p.Glu57fs)" VariationType="Duplication" Accession="VCV002630008" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-19" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2800846" VariationID="2630008">
      <GeneList>
        <Gene Symbol="LOC108021846" FullName="SOX9 promoter region" GeneID="108021846" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="72120285" stop="72122691" display_start="72120285" display_stop="72122691" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SOX9" FullName="SRY-box transcription factor 9" GeneID="6662" HGNC_ID="HGNC:11204" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="72121020" stop="72126416" display_start="72121020" display_stop="72126416" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="70117160" stop="70122560" display_start="70117160" display_stop="70122560" Strand="+" />
          </Location>
          <OMIM>608160</OMIM>
          <Haploinsufficiency last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX9">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX9">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000346.4(SOX9):c.164dup (p.Glu57fs)</Name>
      <CanonicalSPDI>NC_000017.11:72121553:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="72121553" stop="72121554" display_start="72121553" display_stop="72121554" variantLength="1" positionVCF="72121553" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="70117694" stop="70117695" display_start="70117694" display_stop="70117695" variantLength="1" positionVCF="70117694" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>E57fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.70117696dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.70117696dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.72121555dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.72121555dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012490.1" sequenceAccession="NG_012490" sequenceVersion="1" change="g.5536dup">
            <Expression>NG_012490.1:g.5536dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_050876.1" sequenceAccession="NG_050876" sequenceVersion="1" change="g.1371dup">
            <Expression>NG_050876.1:g.1371dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000346.4" sequenceAccession="NM_000346" sequenceVersion="4" change="c.164dup" MANESelect="true">
            <Expression>NM_000346.4:c.164dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000337.1" sequenceAccession="NP_000337" sequenceVersion="1" change="p.Glu57fs">
            <Expression>NP_000337.1:p.Glu57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000346.4(SOX9):c.164dup (p.Glu57fs) AND SOX9-related disorder" Accession="RCV003391310" Version="4">
        <ClassifiedConditionList TraitSetID="90250">
          <ClassifiedCondition>SOX9-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="90250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71956" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">SOX9-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SOX9-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7683378" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="33237285|SOX9-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004111293" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SOX9 c.164dupA variant is predicted to result in a frameshift and premature protein termination (p.Glu57Argfs*195). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in SOX9 are expected to be pathogenic, and therefore we interpret c.164dup (p.Glu57Argfs*195) as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000346.3:c.164dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SOX9-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7683378" TraitType="Disease" MappingType="Name" MappingValue="SOX9-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="SOX9-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

